Friday, February 15, 2019 4:37:54 PM
Mad J.’s toxic lenders, aided and abetted by the third-party promo crew managed to step out about 200K shares, on a reasonable spread and and a much higher than intrinsic price, but 41 trades and crap volume isn’t really going to cut it.
The current batch of toxic trash is about 13-million shares, give or take, that Mad J.’s loan shark pals need to dump. That’s going to take 65 trading days on this pathetic volume trend - way too long, and it’ll collide with Mad J.’s next round of S-3 registered toxic trash. What a train-wreck that’ll be.
MMEX-scam has nothing left to run a pump on - out of ideas, out of even bad lies. Yesterday’s “investor” shite-pitch was beyond pathetic - it’s generally bad, very (5x) bad to disclose to “investors” that estimated costs went from $40-million, to $53-million, to $70-million, then $80-million, and now to $93-million… an increase of 232%…
MMEX-scam couldn’t even provide consistent lies from page to page, and it apparently has two different investor relations representatives (both of whom are doing a very (5x) bad job).
The key in that last foolish disclosure - we find, through Mad J.’s incompetence, that MMEX-scam is working with a bottom-feeding deal broker!
Real companies and business opportunities, legit businesses, legit teams, (unlike MMEX-scam) don’t need deal brokers to obtain capital. Scams like MMEX on the other hand, have no access to legitimate capital sources, so they find some skeevy deal broker to suck scum from the depths on their behalf.
What most OTC “investors” don’t realize is that a deal broker is the kiss of death - no legitimate lender/investor will touch this toxic pile now - the double poison pills of toxic lending, and a deal broker guarantee this thing’s swirling the bowl. Sometimes one has to flush three or four times to make the really big, stinky piles go away.
When you are dead, you don't know that you are dead. It is difficult only for others. It is the same when you are stupid.
Recent MMEX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2024 09:51:51 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 01/08/2024 02:30:21 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 01/03/2024 01:18:51 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/14/2023 03:11:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 04:48:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/14/2023 06:42:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/11/2023 08:50:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 01:30:20 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/17/2023 08:55:16 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM